Stephen Hoge is President at Moderna, Inc. (MRNA). They have made 129 open-market trades across 1 company since 2020, most recently 2026-10-15.
CIK 0001760669
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 129 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRNA | 1,636,565 | $356.0M |
Shares reported on the most recent Form 4, priced at the 2026-10-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRNA | SELL · 10b5-1 | 2026-10-14 | 2026-10-16 | $217.10 | $17.0M | — | — | — |
| MRNA | SELL · 10b5-1 | 2026-09-14 | 2026-09-16 | $145.10 | $11.7M | +28.7% | +41.9% | — |
| MRNA | SELL · 10b5-1 | 2026-07-15 | 2026-07-16 | $67.60 | $3.6M | -9.5% | +4.5% | +265.9% |
| MRNA | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $51.37 | $2.7M | +9.4% | -3.4% | +124.6% |
| MRNA | SELL · 10b5-1 | 2026-05-15 | 2026-05-18 | $48.40 | $2.6M | -0.8% | +29.9% | +35.5% |
| MRNA | SELL | 2026-02-23 | 2026-02-25 | $48.84 | $7.8M | +8.4% | -3.6% | -8.6% |
| MRNA | SELL | 2024-12-03 | 2024-12-04 | $43.30 | $14K | -0.1% | +0.7% | -27.5% |
| MRNA | SELL | 2024-11-29 | 2024-12-02 | $42.79 | $12K | -2.6% | -4.5% | -31.2% |
| MRNA | SELL | 2024-11-11 | 2024-11-12 | $46.10 | $13K | -4.9% | -1.0% | -26.3% |
| MRNA | SELL | 2024-09-03 | 2024-09-04 | $76.99 | $24K | -5.0% | -17.3% | -41.5% |
| MRNA | SELL | 2024-08-29 | 2024-08-30 | $78.03 | $23K | -10.1% | -13.8% | -44.5% |
| MRNA | SELL | 2024-08-12 | 2024-08-13 | $84.10 | $21K | -0.4% | -15.8% | -48.3% |
| MRNA | SELL · 10b5-1 | 2024-07-15 | 2024-07-16 | $121.12 | $1.8M | -0.8% | -29.6% | -53.1% |
| MRNA | SELL · 10b5-1 | 2024-06-17 | 2024-06-18 | $138.16 | $2.1M | -12.5% | -8.5% | -47.8% |
| MRNA | SELL | 2024-06-03 | 2024-06-04 | $140.72 | $48K | -4.6% | -19.4% | -50.3% |
| MRNA | SELL | 2024-05-29 | 2024-05-30 | $144.50 | $49K | -2.4% | -23.8% | -48.5% |
| MRNA | SELL · 10b5-1 | 2024-05-15 | 2024-05-17 | $127.49 | $1.9M | +13.9% | +3.7% | -34.9% |
| MRNA | SELL | 2024-05-10 | 2024-05-13 | $120.96 | $31K | +29.1% | +16.3% | -36.0% |
| MRNA | SELL · 10b5-1 | 2024-04-15 | 2024-04-16 | $105.02 | $1.6M | +2.7% | +26.2% | +15.5% |
| MRNA | SELL · 10b5-1 | 2024-03-15 | 2024-03-19 | $103.17 | $1.5M | +2.1% | -1.4% | +33.4% |
| MRNA | SELL | 2024-03-04 | 2024-03-05 | $94.34 | $29K | +7.8% | +6.1% | +53.4% |
| MRNA | SELL | 2024-02-29 | 2024-03-01 | $94.57 | $452K | +12.5% | +11.6% | +60.1% |
| MRNA | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $100.00 | $1.5M | +4.7% | +17.8% | +75.1% |
| MRNA | SELL | 2024-02-16 | 2024-02-16 | $88.88 | $1.9M | +5.6% | +19.3% | +51.9% |
| MRNA | SELL | 2024-02-12 | 2024-02-13 | $86.23 | $26K | +9.3% | +20.2% | +46.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.